NeuroNav
PrivateLast Round
Early Funding
Nov 28, 2024
Total Funding Raised
$4.21M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NeuroNav operates in Healthcare & Life Sciences and is based in Oakland, California. Its latest recorded funding round was an Early Funding round in November 2024.
NeuroNav is a healthcare technology company that provides services and technology to help people with intellectual and developmental disabilities navigate California's Self-Determination Program.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Vertical SaaS
Business Model
B2G
Customer Profile
Services & Consulting, Government Contracts, Freemium
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroNav Comparables
Compare NeuroNav with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ally Comprehensive Services | 90% | |
| Claudia Cares Consulting, Inc. | 88% | |
| EmpoweredU Independent Facilitators, Inc. | 85% |
For institutional investors. Book with your work email.
NeuroNav Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 28, 2024 | ||||
| Seed | May 27, 2021 | ||||
| Accelerator | Jun 12, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroNav Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| K. Ventures | Early Funding |
| Praxis | Seed |
| Pear VC | Seed |
| Core Innovation Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Grew 18% QoQ, from 17 to 20 employees.
- Jul 31, 2026
Grew 27% QoQ from 15 to 19 employees.
For institutional investors. Book with your work email.
NeuroNav Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroNav's valuation, stock price, and market status.
Is NeuroNav a public or private company?
NeuroNav is a private company.
What is the current stock price of NeuroNav?
NeuroNav is a private company, so its shares have no public market price. Caplight tracks NeuroNav's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroNav worth (valuation)?
Valuation information for NeuroNav is not publicly available.
Can I buy NeuroNav stock?
NeuroNav shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroNav's last funding round?
NeuroNav's most recent funding round was Early Funding on November 28, 2024.
Who are the main investors in NeuroNav?
Key investors in NeuroNav include K. Ventures, Praxis, Pear VC, Core Innovation Capital.
Will NeuroNav IPO soon?
No public IPO plans have been announced for NeuroNav.
How can I track NeuroNav secondary market activity?
Caplight tracks bids, offers, and trades in NeuroNav's shares on secondary markets.